Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy.

52W Range

30thpctl

Volume

0.61×avg

Market Cap

1.88BUSD

P/E Ratio

-TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Braveheart Bio, Inc.

BRVENASDAQ·USD·Closed

Braveheart Bio, Inc.

BRVENASDAQ·USD·Closed

$26.64

−2.24%

$26.64

−$0.61 (2.24%)

52W Range

30thpctl

Volume

0.61×avg

Mkt Cap

1.88BUSD

P/E

–TTM

Div Yield

–ann

BRVE: Braveheart Bio, Inc. Stock Analysis | finqOS